Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Daily Feed
  • Analyst Insights & IR
  • Disclosures
    • Semiconductors
    • Energy
    • Robotics
    • Bio & Healthcare
  • Toggle search form

[Disclosure] Alteogen (196170) Designated as Short-Selling Overheated Stock; Short-Selling Banned on May 19

Posted on May 16, 2025July 11, 2026 By K-STOCK Editor No Comments on [Disclosure] Alteogen (196170) Designated as Short-Selling Overheated Stock; Short-Selling Banned on May 19

Source Fact: Financial Supervisory Service Electronic Disclosure System (DART) / 2025-05-16

Disclosure Type: Designation as Short-Selling Overheated Stock (Short-Selling Trading Ban Applied)

💡 3-Second Summary

Alteogen has been designated as a “Short-Selling Overheated Stock” by the Korea Exchange due to a sharp surge in short-selling volume. Consequently, short-selling activities in both regular and after-hours markets will be strictly prohibited for one day on May 19, 2025.

📊 1. [Summary of Core Disclosure Content and Key Figures]

  • Target Stock: Alteogen (Ticker 196170)
  • Designation Date (Ban Period): May 19, 2025 (Applicable for 1 trading day)
  • Market Action Details: Short-selling trading is prohibited in the regular and after-hours markets on the designation date. Trading will resume under normal short-selling rules from the day after the designation date (May 20).
  • Extension Condition: If the stock price drops by -5% or more on the day short-selling is banned, the short-selling restriction period will be further extended.
  • Permitted Exceptions: Short-selling is exceptionally allowed for liquidity provision quotes (LP), market-making quotes, hedge trading aimed at providing liquidity for ELW, ETF, and ETN products, and market-making hedge quotes in derivatives markets.
  • Special Case: If trading of the designated stock is already suspended on the designation date, no separate actions under this disclosure will be enforced.

📈 2. [Expert Perspective: What This Disclosure Means for Investors]

This disclosure serves as an administrative marker indicating that short-selling trades targeting Alteogen have recently escalated to abnormal levels. It is a regulatory market action enforced under KOSDAQ market operational provisions, rather than an event reflecting a shift in corporate Fundamental, such as biotechnology pipeline developments or revenue revisions.

For investors, the primary metric to follow is the temporary easing of short-side supply pressures, as short-selling is blocked on the target date except for designated hedging transactions. This restriction may exert a positive potential impact by temporarily dampening short-term downward technical pressure. However, because it is a single-day administrative intervention and short-selling can resume on the following day, investors should remain objective and observe intraday price volatility to see if the -5% threshold is tested, which would trigger an extension of the ban.

📝 Editor’s Comment (by K-STOCK Editor)

The Korea Exchange has pulled the emergency brake on short-sellers as speculative volume hit the red zone for Alteogen! For one full session on Monday, May 19, short-selling avenues will be tightly locked down. Excluding standard corporate market-making exceptions, all eyes will be on whether this catalyst sparks brief short-covering support or just a minor breathing room for the stock. Don’t forget the built-in rule: if the stock slips past -5% on the ban day, the short-selling lock gets extended. Keep your terminals open and monitor the bidding blocks closely!

📢 Disclaimer and Source Information

Source: This content has been newly structured and written based on the official data submitted to the Financial Supervisory Service Electronic Disclosure System (DART).

Investment Risk Notice: This content is provided solely for information and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.

Inquiries: For compliance-related inquiries or copyright requests, please contact ksb220805@gmail.com.

🐂
BULLS
VS
🐻
BEARS

🔥 Bulls vs Bears, drop your analysis in the comments!

Disclosures, Bio & Healthcare

Post navigation

Previous Post: [Disclosure] HANMI Semiconductor (042700) to Host Domestic Institutional IR Sponsored by Eugene Investment: Sharing Q1 Performance & Long-Term HBM Growth Blueprint
Next Post: [Disclosure] HANMI Semiconductor (042700) to Launch Global IR Backed by Bank of America: Proclaiming Next-Gen HBM4 Bonder Roadmap to Wall Street Giants

Related Posts

[Disclosure] Alteogen (196170) Lifted from Investment Warning Stock; Designated as Investment Caution Stock for Jan 22 with Warning for Potential Re-designation Disclosures
[Disclosure] Alteogen (196170) to Receive USD 25M (KRW 35.05B) Milestone Payment from MSD Following U.S. FDA Approval of Keytruda SC Disclosures
[Disclosure] Alteogen (196170) to Receive USD 15M (KRW 21.9B) Milestone Payment from MSD Following European Approval of Keytruda SC Disclosures
[Disclosure] Alteogen (196170) to Present Bio Platform and Pipeline Roadmaps at ‘Korea Investment Week 2025’ Disclosures
[Disclosure] Alteogen (196170) Scores Huge Win: Eylea Biosimilar ‘Eyzanfy’ Secures Official MFDS Marketing Approval in South Korea Disclosures
[Disclosure] Alteogen (196170) Announces AGM Results; Re-election of CEO Park Soon-jae and Approval of All Proposed Agendas Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Hana Micron (067310) Lifted from Investment Warning Stock Status; Reclassified to Investment Caution on June 9 with Re-designation WarningJuly 8, 2026
  • [Discount Reversal via ADR Listing and Entry into an HBM-Led Super Cycle: SK hynix 000660]July 7, 2026
  • [Discount Narrowing via ADR Listing Momentum and Capital Allocation Diversification: SK Square 402340]July 7, 2026
  • Gaon Cable (000500): Structural Re-rating Driven by North American Infrastructure Expansion and AI Data Center Demand ShocksJuly 7, 2026
  • Hugel (145020): Passing the Trough with Q2 Earnings Surprise and Accelerated U.S. Direct Sales DeploymentJuly 7, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme